Lipoproteins from Clostridium perfringens and their protective efficacy in mouse model

Area of Science:

• Microbiology and Immunology
• Bacterial Pathogenesis
• Vaccine Development

Background:

• Clostridium perfringens is an anaerobic bacterium causing diseases in humans and animals, recognized as a Validated Biological Agent.
• Previous research identified C. perfringens lipoproteins with potential virulence roles, prompting further investigation into their immunoprotective capabilities.
• Surface-exposed lipoproteins are critical targets for host immune responses and potential vaccine candidates.

Purpose of the Study:

• To evaluate the immuno-protective potential of three specific C. perfringens lipoproteins: polysaccharide deacetylase family protein, probable ion-uptake ABC transporter, and a putative lipoprotein of unknown function.
• To assess the efficacy of these lipoproteins as vaccine candidates against C. perfringens infection.
• To investigate the conservation of related antigenic determinants across other bacterial select agents, particularly within the Firmicutes phylum.

Main Methods:

• Overexpression and purification of three putative virulence-associated lipoproteins from C. perfringens.
• Confirmation of surface exposure of the purified lipoproteins on the bacterial cell.
• Immunization of a mouse model with purified recombinant lipoproteins, followed by challenge with C. perfringens to assess protective immunity.
• Bioinformatic analysis of orthologous proteins in other bacterial select agents to identify conserved antigenic targets.

Main Results:

• The three selected lipoproteins were successfully overexpressed and purified to homogeneity.
• These lipoproteins were confirmed to be surface-exposed and accessible to the host immune system.
• Immunization with the purified recombinant lipoproteins conferred significant protective immunity against C. perfringens challenge in a mouse gas gangrene model.
• Analysis revealed conserved antigenic determinants among orthologous proteins in related bacterial species.

Conclusions:

• The investigated C. perfringens lipoproteins are viable vaccine candidates due to their surface accessibility and demonstrated ability to elicit protective immunity.
• These findings contribute to the development of medical countermeasures against C. perfringens infections.
• The identification of conserved antigenic determinants suggests potential for broader applications in targeting related bacterial pathogens.